Austrianova is one company
that does services that involves high tech, life sciences and biotech. It is together with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science based firm that focuses in the enclosure of living cells or bacteria in little tablets for protection which is also known as cell encapsulation technology, isolation, storage and transportation. We were first formed in the year 2007 and was recognised in Singapore's top study biotech hub, Biopolis that has universal dream in having encapsulation facilities like micro encapsulation.
There is a speedy increasing subject of interest in healthy maintenance and more specifically, in the subject of neutraceuticals which is the teaching and use of probiotic bacteria. Hence, probiotics encapsulation was built. The cell-in-a-box technology was created by Austranova with the goal to defend, isolate, store and move living cells. This proprietary technology can be used for various objectives and can be joined to probiotics, cosmetics and agriculture environmental protection and watching as well as forming the foundation of a authoritative exploration instrument.
In healthcare, this equipment supports facilitates protected implantation of cells or stem cells such as cell therapy, holding them keep away from the immune system and giving long time production of therapeutic molecules in patients. In biotechnology, the cell-in-a-box procedure shields cells in bioreactors and fermentors and at the same time, it make easier purification of bioproducts created from the cells and it shorten manufacture price too.
A huge scale cGMP facility for the manufacturing of biomedical grade encapsulated cell things was beforehand positively constructed and right now, Austrianova is in the development of developing this ability in the whole of SE Asia. This means the use of cell-in-a-box was quite a success for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to allow lower quantities of chemotherapy to be used more productively without the common enervating side consequences. The encapsulated cell are sited, using supraselective catheterisation, into blood vessels that drives to the tumor where they locally convert a chemotherapeutic product to its tumor toxic product.
Visit our site for additional details: Cell Encapsulation, Micro Encapsulation, Encapsulation Services.
